TNFSF10 and prostate carcinoma: The inhibitory effect of EGCG in synergy with TNF-related apoptosis-inducing ligand (TRAIL) on migration and invasion of prostate cancer LNCaP cells was achieved by inhibiting the protein expression of vascular endothelial growth factor (VEGF) and angiopoietin 1 and 2 (112).